The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo
Briana B. Rackley(Emory University), Melissa Gilbert‐Ross(Emory Healthcare)
Cited by 6
Related Papers
Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma
|JCI Insight|2017|69
Live-Cell Invasive Phenotyping Uncovers ALK2 as a Therapeutic Target in <i>LKB1</i> -Mutant Lung Cancer
|Cancer Research|2024|4
Live-cell invasive phenotyping uncovers the ALK2/BMP6 iron homeostasis pathway as a therapeutic vulnerability in LKB1-mutant lung cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1
The level of oncogenic Ras controls the malignant transformation of Lkb1 mutant tissue in vivo
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0
High PER1 expression is associated with STK11 mutation and clinical biomarkers of immunotherapy resistance in lung adenocarcinoma
|Journal of Cancer Research and Clinical Oncology|2025|0